The objective of the study is to evaluate the course and predictors of neuropsychiatric symptoms (NPS) and cognition in patients with de novo Parkinson disease (PD). Methods used include a cross-sectional study of the cohort of de novo, untreated (at enrollment) patients with PD and healthy controls (HCs) from the Parkinson’s Progression Markers Initiative.

This article originally appeared on MPR

READ FULL ARTICLE Curated publisher From www.neurology.org